July 10, 2017 Dr. Wilson Lin Carlsbad, California, 92011 Dear Wilson,
Exhibit 10.1
Employment Offer Letter, dated as of July 10, 2017, between ▇▇▇, Inc. and ▇▇▇▇▇▇ ▇▇▇
▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Ph: ▇▇▇-▇▇▇-▇▇▇▇▇▇▇.▇▇▇.▇▇▇
We are very excited to have you join the ▇▇▇ team and we look forward to working with you. This letter confirms our offer of employment with ▇▇▇, Inc. (“▇▇▇”).
|
1. |
Employment and Duties |
You will be employed by ▇▇▇ as its Chief Operating Officer, reporting to ▇▇▇’▇ Chief Executive Officer (“CEO”), ▇▇. ▇▇▇▇▇▇ ▇▇▇▇▇. Your duties and responsibilities will be assigned to you from the CEO. These responsibilities and duties may change over time. Your principal place of employment will be Carlsbad, California but you will be expected to spend approximately 70% of your working time traveling, primarily to be at Tongmei.
|
2. |
Start Date |
If you accept this offer, you will assume your new position on a date mutually agreeable between you and ▇▇▇, but in any event not later than September 1, 2017 (the date you actually commence employment with ▇▇▇, the “Start Date”).
|
3. |
Base Salary |
In consideration of your services to ▇▇▇, you will receive a starting base salary equal to twenty-five thousand dollars ($25,000.00) per month ($300,000 per year on an annualized basis) (“Base Salary”), which will be payable in accordance with ▇▇▇’▇ normal payroll practices subject to applicable withholdings, and subject to adjustment by ▇▇▇’▇ Board of Directors (the “Board”) from time to time. ▇▇▇ currently processes payroll every two weeks.
While you are employed with ▇▇▇ and the majority of your duties and responsibilities are China‑based (“Assignment Period”) during the period beginning on the date you start employment with ▇▇▇ (the “Start Date”) through the one (1) year anniversary of your Start Date (the “Initial Assignment Period”), ▇▇▇ will provide a salary premium of ten percent (10%) of your Base Salary (the “Salary Premium”), which will be payable in accordance with ▇▇▇’▇ normal payroll practices and subject to applicable withholdings. To the extent that the Assignment Period continues after expiration of such Initial Assignment Period, ▇▇▇ will determine, in good faith in its sole discretion, any continuation thereafter of the Salary Premium. Any Salary Premium will be subject to the terms and conditions of ▇▇▇’▇ expatriate policy as may be in effect from time to time.
During the Initial Assignment Period, you will be eligible to receive a per diem benefit of fifty dollars ($50) per day, payable on a monthly basis and subject to the terms and conditions of ▇▇▇’▇ Expatriate Policy as may be in effect from time to time. This allowance is intended to be used by you to pay the rent on your apartment in China, for food and
Exhibit 10.1
Employment Offer Letter, dated as of July 10, 2017, between ▇▇▇, Inc. and ▇▇▇▇▇▇ ▇▇▇
general other costs and expenses incurred because you are living in China. The amount will be paid to you monthly by Tongmei. During the Initial Assignment Period, this will total $18,250 ($50 times 365 days). To the extent that the Assignment Period continues after expiration of the Initial Assignment Period, ▇▇▇ will determine, in good faith in its sole discretion, any continuation thereafter of the Per Diem Benefit.
Subject to our Board’s approval, you will be granted a restricted stock award covering 120,000 shares of ▇▇▇’▇ common stock (the “RSA”) pursuant to the terms of ▇▇▇’▇ 2015 Equity Incentive Plan and the RSA award agreement thereunder (the “Award Documents”), the terms of which shall supersede any inconsistent term of this letter. Shares subject to this grant shall be scheduled to vest over a four (4) year period according to the following schedule: Twenty-five percent (25%) of the Award will be scheduled to vest on each of the one, two, three and four year anniversaries of the vesting commencement date, subject to your continued employment with ▇▇▇ through such applicable vesting period. Additional grants may be made based on performance at ▇▇▇’▇ discretion.
Within thirty (30) days following your Start Date, ▇▇▇ will pay to you a sign‑on bonus in a lump sum cash amount equal to $40,000, less applicable withholdings, and provided that you are employed with ▇▇▇ on the date such payment is made. If on or prior to the one-year anniversary of your Start Date either you voluntarily terminate your employment with ▇▇▇ for any reason or ▇▇▇ terminates your employment with ▇▇▇ for Cause (as defined below), you must repay to ▇▇▇ within thirty (30) days of your termination of employment the gross amount of the sign-on bonus.
You will be eligible to participate in bonus plans as approved for your position by ▇▇▇. For ▇▇▇’▇ fiscal year 2017, your annual target bonus opportunity will be fifty percent (50%) of your Base Salary (excluding any Salary Premium), which will be prorated based on the number of days that you are employed with ▇▇▇ during the year. ▇▇▇ bonuses are linked to ▇▇▇’▇ financial performance and other performance metrics. Bonuses typically are considered on a quarterly basis, but ultimately are determined by the Board or its Compensation Committee, in their respective discretion.
In the event that you become liable for income taxes in China as a result of your employment with ▇▇▇ during the Assignment Period, ▇▇▇ will provide tax equalization for your tax years covering the Assignment Period so that your aggregate tax liability equals the amount of your US taxes disregarding any China taxes.
You will be required to travel to our Tongmei facility in China to fulfill your job duties and to customer sites in Asia, Europe, North America and elsewhere. You will be entitled to reimbursement by ▇▇▇ for such customary, ordinary, and usual business expenses.
You are eligible to receive up to twelve (12), round‑trip airplane tickets paid by ▇▇▇ for travel for yourself between China and your California residence each year during the Assignment Period. A maximum of three (3) of such round‑trip tickets per year may be used by members of your immediately family. (The cost of family member trips are considered taxable income to you.) These benefits are contingent on your continuing to remain an employee with ▇▇▇ through the completion of each such trip.
Exhibit 10.1
Employment Offer Letter, dated as of July 10, 2017, between ▇▇▇, Inc. and ▇▇▇▇▇▇ ▇▇▇
You will be eligible for health insurance on the first day of the first complete month of your employment. You will be eligible for our 401(k) plan after ninety (90) days from your Start Date. You will be eligible for four (4) weeks of vacation per year, subject to ▇▇▇’▇ vacation policy (including any limitations on accrual) as may be in effect and amended from time to time. Eligibility for additional benefits will commence on your Start Date unless there is a restriction within that benefit. ▇▇▇ reserves the right to modify or terminate its benefit plans and programs it offers to its employees at any time and from time to time as it deems necessary or appropriate.
In the event that your employment with ▇▇▇ is terminated by ▇▇▇ without Cause (as defined in Appendix A attached to this letter) and not as a result of your death or Disability (as defined in Appendix A attached to this letter), then subject to your entering into and not revoking a standard separation agreement and release of claims in favor of ▇▇▇ as described further in Appendix A attached hereto (“Release”), you will receive the following benefits: (a) a lump sum cash payment equal to twelve (12) months of your Base Salary (excluding any Salary Premium) in effect on the date of termination of your employment with ▇▇▇ (“Salary Severance”), and (b) provided that you timely elect to continue coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), for yourself and any of your eligible dependents under ▇▇▇’▇ group health insurance plans following the termination of your employment with ▇▇▇, then ▇▇▇ will pay the COBRA premiums necessary to continue your group health insurance coverage for yourself and your eligible dependents as in effect immediately prior to such termination of your employment until the earliest of (x) twelve (12) months following the termination of your employment with ▇▇▇ (the “Payment Period”), (y) the expiration of your eligibility for continuation coverage under COBRA, or (z) the date when you become eligible for health insurance coverage in connection with other employment, if any (the “COBRA Benefit”). Notwithstanding the foregoing under this Section, if ▇▇▇ determines in its sole discretion that it cannot provide the COBRA Benefit without potentially violating, or being subject to an excise tax under, applicable law (including, without limitation, Section 2716 of the Public Health Service Act and ERISA), then in lieu thereof, ▇▇▇ will provide to you a taxable lump sum payment in an amount equal to the monthly COBRA premium that you would be required to pay to continue the group health coverage in effect on the date of termination of your employment with ▇▇▇ (which amount will be based on the premium for the first month of COBRA coverage) for the Payment Period, which payment will be made regardless of whether you (and/or any eligible dependents) elects COBRA continuation coverage. For the avoidance of doubt, any taxable payments described in this Section may be used for any purpose, including, but not limited to, COBRA continuation coverage, and will be subject to all applicable withholdings.
In the event that your employment with ▇▇▇ is terminated by ▇▇▇ without Cause and such termination occurs upon or within twelve (12) months following a Change in Control, as such term is defined in ▇▇▇’▇ 2015 Equity Incentive Plan, then subject to your entering into and not revoking the Release, and in addition to the Salary Severance and COBRA Benefit described in the immediately preceding paragraph, any unvested and outstanding portion of your then outstanding equity awards will accelerate vesting in full.
▇▇▇ will withhold from any payments or benefits under this letter any applicable U.S. federal, state and local and non‑U.S. taxes required to be withheld and any other required payroll deductions.
Additional terms and conditions applicable to this letter are set forth in the Appendix A attached hereto, which is incorporated herein by reference and made a part of this letter.
While employed by ▇▇▇, and unless otherwise agreed in writing, you agree that you will not undertake any other form of employment or other activity that may negatively affect the performance of your duties as an employee of ▇▇▇. Further, you agree that you will not directly or indirectly engage or assist any person or third party in engaging in any business competitive with the business of ▇▇▇ or any subsidiary or affiliate of ▇▇▇.
Exhibit 10.1
Employment Offer Letter, dated as of July 10, 2017, between ▇▇▇, Inc. and ▇▇▇▇▇▇ ▇▇▇
You will be required to sign ▇▇▇’▇ Proprietary Information and Inventions Agreement which, among other matters, acknowledges that you received, read and agree to diligently adhere to and support ▇▇▇’▇ policies including ▇▇▇’▇:
|
Ø Code of Business Conduct and Ethics |
|
Ø ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ Policy |
|
Ø Related Party Transactions |
|
Ø International Bribery known as the Foreign Corrupt Practices Act |
|
Ø Employee Handbook |
You understand that nothing in this letter or the Proprietary Information and Inventions Agreement shall in any way limit or prohibit you from engaging for a lawful purpose in any Protected Activity. For purposes of this letter and the Proprietary Information and Inventions Agreement, “Protected Activity” shall mean filing a charge, complaint, or report with, or otherwise communicating with, cooperating with or participating in any investigation or proceeding that may be conducted by, any federal, state or local government agency or commission, including the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, and the National Labor Relations Board (“Government Agencies”). You understand that in connection with such Protected Activity, you are permitted to disclose documents or other information as permitted by law, and without giving notice to, or receiving authorization from, ▇▇▇. Notwithstanding the foregoing, you agree to take all reasonable precautions to prevent any unauthorized use or disclosure of any information that may constitute ▇▇▇ confidential information under the Proprietary Information and Inventions Agreement (or any other non‑disclosure agreement) to any parties other than the relevant Government Agencies. You further understand that “Protected Activity” does not include the disclosure of any ▇▇▇ attorney-client privileged communications, and that any such disclosure without ▇▇▇’▇ written consent shall constitute a material breach of this letter and the Proprietary Information and Inventions Agreement. In addition, pursuant to the Defend Trade Secrets Act of 2016, you are notified that an individual will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made in confidence to a federal, state, or local government official (directly or indirectly) or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made under seal. Further, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the individual’s attorney and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.
You understand and agree that employment with ▇▇▇ is for no specific period of time. Your employment with ▇▇▇ is “at will,” meaning that either you or ▇▇▇ may terminate your employment at any time and for any reason, with or without cause. No person at ▇▇▇ has the authority to modify or change the at will nature of your employment except ▇▇▇’▇ CEO and any such modification or change must be in writing, signed by the CEO.
▇▇▇’▇ total liability to you in the event of termination of your employment is limited to the payment of your salary and other earned compensation through the effective date of termination including accrued vacation and any valid expense reports outstanding and if applicable, any severance payments and benefits payable under Section 13 above, subject to the terms and conditions set forth herein.
Your rights and obligations as an employee of ▇▇▇ will be governed by the laws of the State of California without regard to the conflict-of-law provisions thereof. Any unresolved dispute, claim, or controversy arising out of or related to your employment with ▇▇▇ or the termination of that employment shall be resolved exclusively through final and binding arbitration. The location of the arbitration shall be Alameda County or San Francisco, California.
Exhibit 10.1
Employment Offer Letter, dated as of July 10, 2017, between ▇▇▇, Inc. and ▇▇▇▇▇▇ ▇▇▇
This letter (including, for the avoidance of doubt, Appendix A attached hereto), together with the Proprietary Information and Inventions Agreement as well as the Award Documents, represents the entire agreement and understanding between the parties as to the subject matter herein and supersedes all prior or contemporaneous agreements whether written or oral. No waiver, alteration, or modification of any of the provisions of this letter will be binding unless in writing and signed by duly authorized representatives of the parties hereto. In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this letter will continue in full force and effect without said provision. Headings in this letter are for purposes of reference only and will not limit or otherwise affect the meaning hereof.
▇▇▇▇▇▇, we are very pleased to make this offer to you and look forward to you joining the ▇▇▇ team. This offer expires on July 24, 2017, at 5:00 pm. Please sign the enclosed copy of this letter and return it to me as soon as possible.
Very truly yours,
/s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇
▇▇. ▇▇▇▇▇▇ ▇▇▇▇▇
Chief Executive Officer
|
Offer Accepted: |
|
|
|
Signature |
/s/ ▇▇▇▇▇▇ ▇▇▇ |
July 14, 2017 |
|
Printed Name |
Date |
|
|
Intended Start Date: 09/01/2017____________________ |
||
APPENDIX A
Exhibit 10.1
Employment Offer Letter, dated as of July 10, 2017, between ▇▇▇, Inc. and ▇▇▇▇▇▇ ▇▇▇
|
(2) “Disability.” For purposes of the Letter, “Disability” means total and permanent disability as defined in Section 22(e)(3) of the Internal Revenue Code of 1986, as amended (the “Code”). |
The receipt of any severance payments and benefits under the Letter (“Severance Benefits”) is subject to your timely signing and not revoking the Release, which must become effective and irrevocable no later than the sixtieth (60th) day following the termination of your employment (the “Release Deadline Date”). If the Release does not become effective and irrevocable by the Release Deadline Date, you will forfeit any right to the Severance Benefits. In no event will Severance Benefits be paid or provided, or in the case of any installments, begin until the Release actually becomes effective and irrevocable. If the Release becomes effective and irrevocable by the Release Deadline Date, then subject to Sections C and D below, the Severance Benefits will be paid, or in the case of installments, will begin, on the first normally scheduled payroll date of ▇▇▇ immediately after the date that the Release becomes effective and irrevocable, provided that if the Release Deadline Date occurs in the calendar year following the calendar year in which the termination of your employment occurs, then the Severance Benefits will be paid, or in the case of installments, will begin, on the later of (1) the first normally scheduled payroll date of ▇▇▇ occurring immediately after the date on which the Release becomes effective and irrevocable, or (2) the first normally scheduled payroll date of ▇▇▇ occurring immediately after the calendar year in which the termination of your employment occurred (such payment date, the “Severance Start Date”), but in no event later than March 15th of the calendar year following the calendar year in which the termination of your employment occurs, and any Severance Benefits otherwise payable to you during the period immediately following the termination of your employment with ▇▇▇ through the Severance Start Date will be paid in a lump sum to you on the Severance Start Date, with any remaining payments to be made as provided in the Letter (or this Appendix A, as applicable).
Exhibit 10.1
Employment Offer Letter, dated as of July 10, 2017, between ▇▇▇, Inc. and ▇▇▇▇▇▇ ▇▇▇
In no event will you have any discretion with respect to the ordering of payment reductions.
Exhibit 10.1
Employment Offer Letter, dated as of July 10, 2017, between ▇▇▇, Inc. and ▇▇▇▇▇▇ ▇▇▇
Exhibit 10.1
Employment Offer Letter, dated as of July 10, 2017, between ▇▇▇, Inc. and ▇▇▇▇▇▇ ▇▇▇
Section 409A. ▇▇▇ and you agree to work together in good faith to consider amendments to the Letter and this Appendix A and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition before actual payment to you under Section 409A. In no event will ▇▇▇ reimburse you for any taxes imposed or other costs incurred as result of Section 409A. |